The Systemic Immune-inflammation Index (SII) was higher in malignant masses compared to benign masses in both the training and validation sets, but these differences also did not reach statistical significance ( p > 0.05).
← all excerpts
Construction and validation of a preoperative malignancy risk prediction model for ovarian-adnexal masses based on clinical and ultrasonographic features.
1
0.0500
0.0500